209 related articles for article (PubMed ID: 1481725)
1. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay.
Garnero P; Grimaux M; Demiaux B; Preaudat C; Seguin P; Delmas PD
J Bone Miner Res; 1992 Dec; 7(12):1389-98. PubMed ID: 1481725
[TBL] [Abstract][Full Text] [Related]
2. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro.
Garnero P; Grimaux M; Seguin P; Delmas PD
J Bone Miner Res; 1994 Feb; 9(2):255-64. PubMed ID: 8140939
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
Garnero P; Delmas PD
J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
[TBL] [Abstract][Full Text] [Related]
4. Two-site enzyme immunoassay for measuring intact human osteocalcin in serum.
Parviainen M; Kuronen I; Kokko H; Lakaniemi M; Savolainen K; Mononen I
J Bone Miner Res; 1994 Mar; 9(3):347-54. PubMed ID: 8191928
[TBL] [Abstract][Full Text] [Related]
5. [Osteocalcin].
Galli M; Caniggia M
Minerva Med; 1984 Nov; 75(42):2489-501. PubMed ID: 6334818
[TBL] [Abstract][Full Text] [Related]
6. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
7. [Separation and purefied of calf osteocalcin, set up radioimmunoassay for osteocalcin].
Kong Y; Meng X; Zhou X; Liu H; Liu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):257-62. PubMed ID: 10453563
[TBL] [Abstract][Full Text] [Related]
8. Immunoradiometric assay measurements of insulin-like growth factor-I (IGF-I): comparison with radioimmunoassays using native or des (1-3) IGF-I as radioligands.
Homayoun P; Daher R; Van Lente F; Faiman C; Gupta MK
J Clin Lab Anal; 1996; 10(6):446-50. PubMed ID: 8951618
[TBL] [Abstract][Full Text] [Related]
9. Influence of type and breed of horse on serum osteocalcin concentration, and evaluation of the applicability of a bovine radioimmunoassay and a human immunoradiometric assay [corrected].
Lepage OM; Eicher R; Uebelhart B; Tschudi P
Am J Vet Res; 1997 Jun; 58(6):574-8. PubMed ID: 9185960
[TBL] [Abstract][Full Text] [Related]
10. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
Torres R; de la Piedra C; Rapado A
Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
[TBL] [Abstract][Full Text] [Related]
11. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.
Frystyk J; Ivarsen P; Støving RK; Dall R; Bek T; Hagen C; Ørskov H
Growth Horm IGF Res; 2001 Apr; 11(2):117-27. PubMed ID: 11472078
[TBL] [Abstract][Full Text] [Related]
12. A dual-label immunofluorometric assay for human osteocalcin.
Ylikoski A; Hellman J; Matikainen T; Käkönen SM; Karp M; Väänänen HK; Lövgren T; Pettersson K
J Bone Miner Res; 1998 Jul; 13(7):1183-90. PubMed ID: 9661083
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of bone Gla-protein in normal humans and in patients with chronic renal failure.
Sugimoto K; Dohi Y; Dohi K; Yonemasu K; Fujimoto J; Kanauchi M; Yamanaka F; Moriyama T; Ishikawa H
Miner Electrolyte Metab; 1987; 13(3):152-7. PubMed ID: 3498115
[TBL] [Abstract][Full Text] [Related]
14. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients.
Ureña P; Ferreira A; Kung VT; Morieux C; Simon P; Ang KS; Souberbielle JC; Segre GV; Drüeke TB; De Vernejoul MC
J Bone Miner Res; 1995 Jun; 10(6):932-9. PubMed ID: 7572317
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
Singh AK; Avula S; Kher V; Rao DS; Mithal A
Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
[TBL] [Abstract][Full Text] [Related]
17. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
[TBL] [Abstract][Full Text] [Related]
18. An immunoradiometric assay for measurement of serum thyroglobulin.
Rajashekharrao B; Kumar A; Velumani A; Shah DH
Indian J Med Res; 1992 Dec; 96():350-5. PubMed ID: 1289247
[TBL] [Abstract][Full Text] [Related]
19. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
Motz W
Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of nine monoclonal antibodies against osteocalcin: combinations into two-site assays affect both assay specificity and sample stability.
Hellman J; Käkönen SM; Matikainen MT; Karp M; Lövgren T; Väänänen HK; Pettersson K
J Bone Miner Res; 1996 Aug; 11(8):1165-75. PubMed ID: 8854253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
